23andMe is a genomics and biotechnology company where it focuses on human genome research to help individuals access, understand and benefit from the human genome. Having more than 10,000,000 customers, 23andMe has collected one billion phenotypic data points, which enables them to revolutionize health, wellness, and research. It is establishing a new world centered on customers where it improves healthcare, prevents disease, and allows individuals to control their health data.
35 Reviews
Talented peers, Employees are treated very well, WLB has been great, CEO is passionate
Subpar compensation, Lot of uncertainty regarding cash flow and business future, People seem to be rewarded and promoted based only on how vocal they are, not their actual work. Diversity efforts are very forced and shallow
The research is said to be the biggest study on dyslexia to date.
The new research study that is being offered here is an excellent compilation of numerous analyses of important elements of the Global Human Genome Sequencing Market It clarifies how the Human Genome Sequencing market is anticipated to expand globally over ...
US$ 190,000
Median Total Comp
25TH%
70TH%
90TH%
